News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

Posts of category: Partner News

Recent announcements, achievements, and development milestones from PARI's pharmaceutical partners utilizing eFlow® Technology.

Published

December 16, 2019

Category

Partner News

Kamada Announces Enrollment of First Patient into its Pivotal Phase 3 InnovAATe Clinical Trial of Inhaled AAT for the Treatment of Alpha-1 Antitrypsin Deficiency

Published

September 10, 2019

Category

Partner News

Santhera Announces Publication of Phase I Clinical Data with POL6014 in Journal of Cystic Fibrosis

Published

July 25, 2019

Category

Partner News

PARI Pharma spin-out Breath Therapeutics acquired by Zambon Pharma

Published

May 20, 2019

Category

Partner News

New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with Refractory MAC Lung Disease

Published

May 1, 2019

Category

Partner News

Sunovion to Present Data on LONHALA® MAGNAIR® Inhalation Solution and COPD at the American Thoracic Society International Conference 2019